Tech Company Financing Transactions
Beta Bionics Funding Round
On 11/15/2024, Beta Bionics raised $60 million in Series E investment from Wellington Management Company, Eventide Asset Management and Marshall Wace.
Transaction Overview
Company Name
Announced On
11/15/2024
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series E
Investors
Proceeds Purpose
The company intends to use the funds to support expanded commercialization of the iLet Bionic Pancreas and develop the product pipeline.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
11 Hughes
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Born out of a real customer need from one of our own. A family learning to manage life, after their infant son developed type 1 diabetes. Many of us on the Beta Bionics team live with, or care for, someone with diabetes. We draw inspiration and drive from our personal and collective experiences, to be a force for good for the diabetes community.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Saint
Chief Financial Officer
Stephen Feider
Chief Medical Officer
Steven Russell
Founder
Ed Damiano
VP - Bus. Development
Tony Galliani
VP - Bus. Development
Mark Hopman
VP - General Counsel
Kevin Meinert
VP - Marketing
Karen Hynes
VP - Operations
David Henderson
VP - Product Management
Mike Mensinger
VP - R & D
Himanshu Patel
VP - Regulatory Affairs
Joe Conkey
VP - Regulatory Affairs
Douglas Ferguson
Browse more venture capital transactions:
Prev: 11/15/2024: Gendo venture capital transaction
Next: 11/15/2024: PMWeb venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs